Literature DB >> 16949872

Germinal-centre reactions in allergic inflammation.

Hannah J Gould1, Pooja Takhar, Helen E Harries, Stephen R Durham, Christopher J Corrigan.   

Abstract

Primary and secondary immune responses in the germinal centres of lymphoid organs have been studied in the past. There is now compelling evidence of a third stage in the immune response, in 'tertiary lymphoid organs' that develop at sites of chronic inflammation in response to persistent local antigen challenge. Germinal-centre-like reactions are well-documented in the target organs of autoimmune diseases. Here, we review recent evidence that they also occur at sites of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949872     DOI: 10.1016/j.it.2006.08.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  17 in total

1.  Random allergen-specific IgE expression in atopic families: evidence for inherited "stochastic bias" in adverse immune response development to non-infectious antigens.

Authors:  Duaine R Jackola
Journal:  Mol Immunol       Date:  2007-01-23       Impact factor: 4.407

Review 2.  The role of local allergy in the nasal inflammation.

Authors:  Ke-Jia Cheng; Min-Li Zhou; Ying-Ying Xu; Shui-Hong Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-17       Impact factor: 2.503

3.  Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement.

Authors:  Agnès Hamzaoui; Hanene Chelbi; Fayçal Hai Sassi; Kamel Hamzaoui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

4.  Composition of the immunoglobulin classic antigen-binding site regulates allergic airway inflammation in a murine model of experimental asthma.

Authors:  S Kerzel; J Wagner; T Rogosch; A-O Yildirim; L Sikula; H Fehrenbach; H Garn; R F Maier; H W Schroeder; M Zemlin
Journal:  Clin Exp Allergy       Date:  2009-02-03       Impact factor: 5.018

5.  Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects.

Authors:  Atsushi Kato; Huiqing Xiao; Regina T Chustz; Mark C Liu; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2009-01-09       Impact factor: 10.793

6.  CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation.

Authors:  Daniel Perez-Witzke; María Auxiliadora Miranda-García; Nuris Suárez; Raquel Becerra; Kharelys Duque; Verónica Porras; Jaheli Fuenmayor; Ramon Fernando Montano
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

Review 7.  The production and regulation of IgE by the immune system.

Authors:  Lawren C Wu; Ali A Zarrin
Journal:  Nat Rev Immunol       Date:  2014-03-14       Impact factor: 53.106

8.  Shaping of infant B cell receptor repertoires by environmental factors and infectious disease.

Authors:  Sandra C A Nielsen; Krishna M Roskin; Katherine J L Jackson; Shilpa A Joshi; Parastu Nejad; Ji-Yeun Lee; Lisa E Wagar; Tho D Pham; Ramona A Hoh; Khoa D Nguyen; Hannah Y Tsunemoto; Sonal B Patel; Robert Tibshirani; Catherine Ley; Mark M Davis; Julie Parsonnet; Scott D Boyd
Journal:  Sci Transl Med       Date:  2019-02-27       Impact factor: 17.956

9.  Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis.

Authors:  M Vicario; C Blanchard; K F Stringer; M H Collins; M K Mingler; A Ahrens; P E Putnam; J P Abonia; J Santos; M E Rothenberg
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

10.  Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.

Authors:  Panagiotis Karagiannis; Josef Singer; James Hunt; Samuel K E Gan; Sarah M Rudman; Diana Mechtcheriakova; Regina Knittelfelder; Tracy R Daniels; Philip S Hobson; Andrew J Beavil; James Spicer; Frank O Nestle; Manuel L Penichet; Hannah J Gould; Erika Jensen-Jarolim; Sophia N Karagiannis
Journal:  Cancer Immunol Immunother       Date:  2008-10-22       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.